HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Joseph R Testa Selected Research
Joseph R Testa Research Topics
Disease
96
Neoplasms (Cancer)
04/2024 - 01/2002
42
Malignant Mesothelioma
04/2024 - 01/2002
25
Mesothelioma
04/2024 - 02/2002
14
Carcinogenesis
12/2022 - 01/2002
11
Ovarian Neoplasms (Ovarian Cancer)
07/2013 - 07/2004
9
Renal Cell Carcinoma (Grawitz Tumor)
12/2022 - 11/2005
9
Carcinoma (Carcinomatosis)
07/2013 - 01/2002
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
10/2020 - 08/2011
5
Inflammation (Inflammations)
12/2022 - 08/2010
5
Lymphoma (Lymphomas)
10/2020 - 01/2010
5
Neurofibromatosis 2 (Neurofibromatosis Type II)
11/2018 - 01/2004
4
Melanoma (Melanoma, Malignant)
06/2022 - 01/2013
3
Necrosis
01/2022 - 08/2013
3
Leukemia
10/2020 - 02/2017
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2020 - 08/2011
3
T-Cell Lymphoma (Lymphoma, T Cell)
02/2017 - 06/2015
3
Pancreatic Neoplasms (Pancreatic Cancer)
02/2015 - 01/2002
3
Adenocarcinoma
02/2015 - 11/2004
3
Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2013 - 06/2008
3
Infections
06/2008 - 02/2002
2
Bites and Stings (Sting)
12/2022 - 10/2022
2
Hypoxia (Hypoxemia)
10/2022 - 05/2002
2
Genomic Instability
06/2022 - 10/2007
2
Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2019
2
Sarcoma (Soft Tissue Sarcoma)
06/2019 - 01/2016
2
Tuberous Sclerosis (Bourneville's Disease)
03/2017 - 12/2004
2
Lung Neoplasms (Lung Cancer)
10/2015 - 10/2006
2
Neoplasm Metastasis (Metastasis)
02/2015 - 03/2013
2
Ascites
02/2014 - 11/2004
2
Genetic Predisposition to Disease (Genetic Predisposition)
06/2008 - 07/2006
1
Microsatellite Instability
06/2022
1
Asbestosis
01/2022
Drug/Important Bio-Agent (IBA)
35
Asbestos
IBA
04/2024 - 01/2002
17
Proteins (Proteins, Gene)
FDA Link
12/2022 - 02/2002
13
DNA (Deoxyribonucleic Acid)
IBA
01/2021 - 02/2002
11
Phosphotransferases (Kinase)
IBA
01/2022 - 01/2002
8
Transcription Factors (Transcription Factor)
IBA
12/2022 - 08/2011
7
RNA (Ribonucleic Acid)
IBA
01/2022 - 02/2010
6
Everolimus
FDA Link
10/2020 - 03/2007
6
Cisplatin (Platino)
FDA Link
Generic
04/2015 - 07/2004
6
Neurofibromin 2 (Merlin)
IBA
05/2014 - 01/2002
5
TOR Serine-Threonine Kinases
IBA
02/2015 - 03/2007
4
Small Interfering RNA (siRNA)
IBA
12/2022 - 09/2009
4
ErbB Receptors (EGF Receptor)
IBA
01/2022 - 06/2007
4
Cytokines
IBA
02/2016 - 07/2006
4
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
04/2015 - 03/2007
3
Oncogene Proteins (Oncogene Protein)
IBA
01/2022 - 11/2005
3
erionite
IBA
01/2022 - 02/2002
3
Carcinogens
IBA
01/2022 - 06/2008
3
Sirolimus (Rapamycin)
FDA Link
10/2020 - 09/2005
3
Catenins
IBA
01/2020 - 05/2013
3
Ribosomal Proteins (Ribosomal Protein)
IBA
01/2019 - 11/2012
3
Tumor Suppressor Protein p14ARF (p14ARF)
IBA
11/2018 - 02/2002
3
Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)
IBA
11/2011 - 06/2007
3
Telomerase (Telomerase Reverse Transcriptase)
IBA
11/2011 - 02/2002
3
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
03/2009 - 07/2006
3
NF-kappa B (NF-kB)
IBA
03/2009 - 11/2004
3
Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
IBA
06/2007 - 05/2002
2
Crocidolite Asbestos (Blue Asbestos)
IBA
04/2024 - 11/2011
2
Interleukin-6 (Interleukin 6)
IBA
12/2022 - 02/2010
2
Interferons
IBA
12/2022 - 10/2022
2
Interferon-Stimulated Gene Factor 3
IBA
12/2022 - 10/2022
2
Interferon-beta
IBA
12/2022 - 10/2022
2
Interferon Type I
IBA
12/2022 - 10/2022
2
Deubiquitinating Enzymes
IBA
10/2022 - 01/2021
2
secoisolariciresinol diglucoside
IBA
09/2022 - 02/2016
2
Thymine DNA Glycosylase
IBA
06/2022 - 01/2019
2
Vimentin
IBA
01/2022 - 11/2005
2
p21-Activated Kinases
IBA
01/2022 - 09/2012
2
Viral Proteins
IBA
01/2021 - 11/2008
2
Complementary DNA (cDNA)
IBA
01/2021 - 10/2002
2
Ubiquitin Thiolesterase (Ubiquitin Carboxy-Terminal Hydrolase)
IBA
01/2021 - 01/2018
2
Fluorouracil (Carac)
FDA Link
Generic
01/2019 - 09/2012
2
Cyclin-Dependent Kinase Inhibitor p16
IBA
11/2018 - 04/2011
2
Enzymes
IBA
01/2018 - 01/2013
2
Biomarkers (Surrogate Marker)
IBA
06/2017 - 02/2015
2
trans-sodium crocetinate (crocetin)
IBA
03/2017 - 12/2004
2
Messenger RNA (mRNA)
IBA
02/2017 - 08/2011
2
Chromatin
IBA
01/2016 - 05/2015
2
Bevacizumab (Avastin)
FDA Link
04/2015 - 08/2010
2
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
09/2012 - 06/2008
2
Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)
IBA
10/2009 - 05/2004
2
Cyclin D1
IBA
03/2007 - 03/2005
2
Hematoxylin (Haematoxylon)
IBA
11/2005 - 07/2004
2
Eosine Yellowish-(YS) (Eosin)
IBA
11/2005 - 07/2004
2
Tumor Viral Antigens (Large T Antigen)
IBA
06/2005 - 02/2002
2
2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- one
IBA
07/2004 - 05/2002
2
A-Form DNA (A-DNA)
IBA
02/2002 - 02/2002
1
Amphibole Asbestos
IBA
04/2024
1
Adenosine (Adenocard)
FDA Link
Generic
04/2024
1
Serpentine Asbestos (Chrysotile)
IBA
04/2024
1
DNA Polymerase theta
IBA
11/2023
1
Glycoproteins (Glycoprotein)
IBA
12/2022
1
Keratin-8 (Keratin 8)
IBA
12/2022
1
LGM2605
IBA
09/2022
1
MME
IBA
06/2022
Therapy/Procedure
20
Therapeutics
11/2023 - 01/2004
4
Nephrectomy
01/2020 - 07/2004
4
Drug Therapy (Chemotherapy)
01/2017 - 09/2005
2
Chemoprevention
12/2022 - 02/2016